Antibiotic Accelerator From BARDA Nears Investment Stage
This article was originally published in The Pink Sheet Daily
Federal funding could pay to help early antibiotic discovery efforts with 'fragile' pipeline still struggling.
You may also be interested in...
FDA asks groups how it can help ensure prescribing is limited for products approved under proposed new pathway, but several say, other than labeling, it may be out of the agency’s hands.
The system likely will evolve as the post-pandemic world unfolds, but adds to the list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.
Virtual meetings proved successful, and could be allowed again when the next round of user fee reauthorization talks convene.